Pro-inflammatory effects induced by bradykinin in a murine model of pleurisy

European Journal of Pharmacology

Volumn 331, Issue 1, 1997, Pages 43-52

  Saleh, Tânia S F ^a   Calixto, João B ^a   Medeiros, Yara S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anti inflammatory drugs; Bradykinin; Bradykinin receptor antagonist; Inflammatory mediator

Indexed keywords

ARGININE DERIVATIVE; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ DERIVATIVE; CROMOGLYCATE DISODIUM; DEXAMETHASONE; ICATIBANT; INDOMETACIN; N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE; NPC 17731; OSANETANT; SALBUTAMOL; TERFENADINE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAPLEURAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PLEURISY; PRIORITY JOURNAL;

ANIMALS; BENZAMIDES; BRADYKININ; CELL MOVEMENT; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INDOLES; INFLAMMATION; LEUKOCYTE COUNT; MALE; MICE; NEUTROPHILS; OLIGOPEPTIDES; PIPERIDINES; PLEURA; PLEURISY; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; TIME FACTORS;

EID: 0030796054     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01005-4     Document Type: Article

References (53)

1. 1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am. J. Physiol. 269, 309-317.
2. Bathon, J.M., Proud, D., 1991. Bradykinin antagonists. Ann. Rev. Pharmacol. 31, 129-163.
3. Becker, J.W., Bierman, C.W., 1994. Prophylactic anti-asthma drugs. In: Page, C.P., Metzer, W.J. (Eds.), Drugs in the Lung. Raven Press, New York, NY, pp. 221-249.
4. Belvisi, M.G., Patacchini, R., Barnes, P.J., Maggi, C.A., 1994. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: Evidence for species differences. Br. J. Pharmacol. 111, 103-110.
5. Bertrand, C., Nadel, J.A., Yamawaki, I., Geppetti, P., 1993. Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea-pig trachea. J. Immunol. 151, 4902-4907.
6. Bhoola, K.D., Figueroa, C.D., Worthy, K., 1992. Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80.
7. Brito, F.D., 1989. Pleurisy and pouch models of acute inflammation. In: Liss, A.A.R. (Ed.), Pharmacological Methods in The Control of Inflammation. Rhone Poulenc, Dagenham, pp. 173-228.
8. Burch, R.M., De Haas, C., 1990. A bradykinin antagonist inhibits carragenin edema in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 342, 189-193.
9. Burch, R.M., Farmer, S.G., Steranka, L., 1990. Bradykinin receptor antagonist. Med. Res. Rev. 10, 237-269.
10. Burch, R.M., Kyle, D.J., Storemenn, J.M., 1993. Transduction of bradykinin signals. In: Burch, R.M., Kyle, D.J., Storemenn, J.M., (Eds.), Molecular Biology and Pharmacology of Bradykinin Receptors. Landes, Austin, TX, pp. 33-56.
11. 2 receptor in bradykinin-induced rat paw oedema. Br. J. Pharmacol. 114, 1005-1013.
12. 1 kinin receptors mediating paw oedema and formalin-induced nociception. Modulation by glucocorticoids. Can. J. Physiol. Pharmacol. 73, 812-819.
13. Canning, B.J., Undem, B.J., 1994. Evidence that antidromically stimulated vagal-afferents activate inhibitory neurones innervating guineapig trachealis. J. Physiol. 480, 613-625.
14. 3 receptor. Mol. Pharmacol. 48, 711-716.
15. 2 kinin receptors in formalin-induced nociceptive response in the mouse. Br. J. Pharmacol. 110, 193-198.
16. Crescioli, S., Spinazzi, A., Plebani, M., Pozzani, M., Mapp, C.E., Boschetto, P., Fabbri, L.M., 1991. Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects. Ann. Allergy 66, 245-251.
17. 1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br. J. Pharmacol. 113, 940-944.
18. Damas, J., Bovrdon, V., Remacle-Volon, G., Adam, A., 1990. Kinins and peritoneal exudates induced by carrageenin and zymosan in rats. Br. J. Pharmacol. 2, 418-422.
19. 1 receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat. Neuropharmacology 33, 127-133.
20. 2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Br. J. Pharmacol. 113, 63-68.
21. 9-Bradykinin. Br. J. Pharmacol. 93, 969-977.
22. Dray, A., Perkins, M.N., 1993. Bradykinin and inflammatory pain. Trends Neurosci. 16, 99-104.
23. Dray, A., Urban, L., Dickenson, A., 1994. Pharmacology of chronic pain. Trends Pharmacol. Sci. 15, 190-197.
24. Erjefalt, L., Persson, C.G., 1991. Pharmacological control of plasma exudation in tracheobronquial airways. Am. Rev. Resp. Dis. 143, 1008-1014.
25. Farmer, S.G., Burch, R.M., 1992. Biochemical and molecular pharmacology of kinin receptors. Ann. Rev. Pharmacol. Toxicol. 32, 511-536.
26. Geppetti, P., 1993. Sensory neuropeptide released by bradykinin: Mechanisms and pathological implications. Regul. Pept. 47, 1-23.
27. Geppetti, P., Bertrand, C., Ricciardolo, M.L., Nadel, J.A., 1995. New aspects on the role of kinins in neurogenic inflammation. Can. J. Pharmacol. 73, 843-847.
28. 2 release, nociceptor stimulation and contraction of the iris sphincter muscle in the rabbit. Br. J. Pharmacol. 92, 330-340.
29. Griesbacher, T., Lembeck, F., Saria, A., 1989. Effect of the bradykinin antagonist B4310 on smooth muscle and blood pressure in the rat, and its enzymatic degradation. Br. J. Pharmacol. 96, 531-538.
30. Hall, J.M., 1992. Bradykinin receptors: Pharmacological properties and biological roles. Pharmacol. Ther. 56, 131-190.
31. Hall, J.M., Geppetti, P., 1995. Kinins and kinin receptors in the nervous system. Neurochem. Int. 26, 17-26.
32. Kyle, D.J., Martin, J.A., Burch, R.M., Carter, J.P., L.U., S., Meeker, S., Prosser, J.C., Sullivan, J.P., Togo, S., Noronha-Blob, L., Sunsko, J.A., Walters, R.F., Wahley, L.W., Hiner, R.N., 1991. Probing the bradykinin receptor: Mapping the bradykinin receptor: Mapping the geometric topography using ethers of hydroxyproline in novel peptides. J. Med. Chem. 34, 2649-2653.
33. Lembeck, F., Griesbacher, T., Eckhardt, M., Henke, S., Breipohe, G., Knolle, J., 1991. New, long-lasting, potent bradykinin antagonists. Br. J. Pharmacol. 102, 297-304.
34. Lembeck, F., Griesbacher, T., Legat, F.J., 1992. Lack of significant effects of HOE 140 and other novel bradykinin antagonists in vitro and in vivo. Agents Actions 38, 414-422.
35. 1 receptor: A review. Immunopharmacology 30, 1-26.
36. Martins, A.M., Pasquale, C.P., Bozza, P.T., Silva, M.R., Faria Neto, H.C.C., Cordeiro, R.S.B., 1992. Homologous tachyphylaxis to bradykinin and its interference with allergic pleurisy in actively sensitized rats. Eur. J. Pharmacol. 220, 55-61.
37. Moskowitz, M.A., MacFarlane, R., 1993. Neurovascular and molecular mechanisms in migraine headaches. In: Cerebrovascular and Brain Metabolism Reviews. Raven Press, New York, NY, pp. 159-177.
38. Paegelow, I., Werner, H., Vietinghoff, Wartner, V., 1995. Release of cytokines from isolated lung strips by bradykinin. Inflamm. Res. 44, 306-311.
39. Pasquale, C.P., Martins, M.A., Bozza, P.T., Silva, P.M.R., Faria Neto, H.C.C., 1991. Bradykinin induces eosinophil accumulation in the rat pleural cavity. Arch. Allergy Appl. Immunol. 95, 244-247.
40. Patacchini, R., Maggi, C.A., 1995. Tachykinin receptors and receptor subtypes. Arch Int. Pharmacol. Ther. 329, 161-183.
41. Patacchini, R., Astolfi, L., Quartara, P., Rovero, A., Giachetti, A., Maggi, C.A., 1991. Further evidence for the existence of NK2 tachykinin receptor subtypes. Br. J. Pharmacol. 104, 91-96.
42. 1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br. J. Pharmacol. 110, 1441-1444.
43. Pethö, G., Jocic, M., Holzer, P., 1994. Role of bradykinin in the hyperaemia following acid challenge of the rat gastric mucosa. Br. J. Pharmacol. 113, 1036-1042.
44. Regoli, D., Barabé, J., 1980. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32, 1-46.
45. 2-receptor antagonists. Hypertension 17, 107-115.
46. Ricciardolo, F.L.M., Nadel, J.A., GAF, P.D., Bertrand, C., Yoshihara, S., Geppetti, P., 1994. Role of kinins in anaphylactic-induced bronchoconstriction mediated by tachykinins in guinea-pig. Br. J. Pharmacol. 113, 508-512.
47. Saleh, T.S.F., Calixto, J.B., Medeiros, Y.S., 1996. Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy. Br. J. Pharmacol. 118, 811-819.
48. Shelhamer, J.H., Leaven, S.J., WU, T., Jacoby, D.B., Kaliner, M.A., Rennard, S.I., 1995. Airway inflammation. Ann. Int. Med. 123, 288-304.
49. Steranka, L.R., Burch, R.M., 1991. Bradykinin antagonists in pain and in inflammation. In: Burch, R.M. (Ed.), Bradykinin Antagonists: Basic Clinical Research. Marcel Dekker, New York, NY, pp. 191-211.
50. Wirth, K., Hock, F.J., Alibis, U., Liz, W., Alderman, H.G., Anagnostopoulos, H., Henke, S., Breipohl, G., Köning, W., Knolle, J., Shölkens, B.A., 1991. HOE 140, a new potent and long acting bradykinin-antagonist: In vivo studies. Br. J. Pharmacol. 102, 774-778.
51. Wirth, K.J., Gehring, D., Shölkens, B.A., 1993. Effect of HOE 140 on bradykinin-induced bronchoconstriction in anesthetized guinea pigs. Am. Rev. Resp. Dis. 148, 702-706.
52. Wirth, K.J., Heitsh, H., Shölkens, B.A., 1995. Kinin receptor antagonists: Unique probes in basic and clinical research. Can. J. Physiol. Pharmacol. 73, 797-804.
53. Zimmermann, M., 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109-110.